The Build Back Better Act “Will Make Our System Work Better For Those It Is Intended To Serve: Patients And All Americans”
Government And Taxpayers Saved The Day; Drug Corporations Did Their Job, Then Cashed In
Patients For Affordable Drugs Responds To The Industry’s $18 Million Attack Ads Aimed At Thwarting Reforms To Lower Drug Prices
Right now, Big Pharma is bankrolling an ad campaign worth tens of millions of dollars against the reforms that would allow Medicare to negotiate lower drug prices.
The FDA’s approval of Semglee as an interchangeable biosimilar to Lantus is an important step forward on the road to real competition.
Patients For Affordable Drugs’ Analysis Highlights Need For Medicare Negotiation For All Drugs
Take a look at this year's price hikes to see why Congress must act now.
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.
